Vident Investment Advisory’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,660
Closed -$443K 981
2018
Q3
$443K Sell
4,660
-46,200
-91% -$3.94M 0.02% 736
2018
Q2
$3.93M Sell
50,860
-798
-2% -$59.9K 0.16% 124
2018
Q1
$3.75M Sell
51,658
-1,581
-3% -$121K 0.15% 134
2017
Q4
$3.97M Buy
53,239
+1,296
+2% +$82.9K 0.18% 99
2017
Q3
$3.29M Buy
51,943
+14,101
+37% +$876K 0.18% 111
2017
Q2
$2.42M Buy
37,842
+679
+2% +$42.6K 0.2% 187
2017
Q1
$2.45M Buy
37,163
+6,236
+20% +$429K 0.24% 170
2016
Q4
$2.13M Buy
30,927
+264
+0.9% +$18.9K 0.26% 201
2016
Q3
$2.16M Buy
+30,663
New +$2.29M 0.29% 187
2015
Q4
Sell
-11,931
Closed -$966K 979
2015
Q3
$966K Buy
11,931
+229
+2% +$19.9K 0.13% 199
2015
Q2
$1.04M Buy
11,702
+867
+8% +$75.7K 0.14% 198
2015
Q1
$940K Buy
10,835
+11
+0.1% +$923 0.19% 141
2014
Q4
$916K Buy
+10,824
New +$846K 0.31% 58

Other funds holding ESRX

Vident Investment Advisory's ESRX Position: Q4 2018 in Review

Vident Investment Advisory sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 4,660 shares — an estimated $443K sold.

Vident Investment Advisory first reported a position in ESRX in Q4 2014 and held it in 13 quarters. The position peaked at $3.97M in Q4 2017. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Vident Investment Advisory reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Vident Investment Advisory sold 4,660 Express Scripts Holding Company shares in Q4 2018, an estimated $443K.
  • Vident Investment Advisory first reported a position in Express Scripts Holding Company in Q4 2014 and held it in 13 quarters.
  • Vident Investment Advisory's Express Scripts Holding Company position peaked at $3.97M in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Vident Investment Advisory's 13F filing for Q4 2018, filed 14 Feb 2019.